|
CENPL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.572000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.025400E-01 |
| Normal-vs-Stage2 |
1.590610E-01 |
| Normal-vs-Stage3 |
4.781100E-03 |
| Normal-vs-Stage4 |
1.342370E-01 |
| Stage1-vs-Stage2 |
2.540600E-01 |
| Stage1-vs-Stage3 |
8.980200E-04 |
| Stage1-vs-Stage4 |
6.464000E-02 |
| Stage2-vs-Stage3 |
1.027190E-01 |
| Stage2-vs-Stage4 |
3.287200E-01 |
| Stage3-vs-Stage4 |
7.668200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.555440E-01 |
| Normal-vs-AfricanAmerican |
3.346800E-01 |
| Normal-vs-Asian |
2.132200E-01 |
| Caucasian-vs-AfricanAmerican |
9.430600E-01 |
| Caucasian-vs-Asian |
2.104600E-01 |
| AfricanAmerican-vs-Asian |
1.594570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.890000E-01 |
| Normal-vs-Female |
9.648900E-04 |
| Male-vs-Female |
1.339600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.636450E-01 |
| Normal-vs-Extreme_Weight |
1.341620E-01 |
| Normal-vs-Obese |
8.437700E-02 |
| Normal-vs-Extreme_Obese |
6.974200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.614100E-02 |
| Normal_Weight-vs-Obese |
8.606400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.985150E-01 |
| Extreme_Weight-vs-Obese |
6.739500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.708200E-01 |
| Obese-vs-Extreme_Obese |
2.900200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.246300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.404500E-02 |
| Normal-vs-Age(61-80Yrs) |
6.817600E-01 |
| Normal-vs-Age(81-100Yrs) |
2.587400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.334450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.467800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.671600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.957900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.563900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.532600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.962800E-01 |
| Normal-VS-Type2 PRCC |
8.844500E-03 |
| Normal-VS-KIRP CIMP |
3.666200E-02 |
| Normal-VS-Unclassified PRCC |
3.414400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.078200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.644100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.844400E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.233600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.273400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.731800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.256600E-01 |
| Normal-vs-N1 |
2.280100E-03 |
| Normal-vs-N2 |
4.208000E-01 |
| N0-vs-N1 |
1.110260E-02 |
| N0-vs-N2 |
7.583200E-01 |
| N1-vs-N2 |
3.367000E-01 |
|
|
